Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

University of Arizona

Status and phase: Completed; Phase 2

Conditions: Urinary Retention Postoperative

Treatments: Drug: Placebo; Drug: Tamsulosin

Study type: Interventional

Funder types: Other

Identifiers

NCT04859660

2102483026

Details and patient eligibility

About

The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.

Enrollment: 161 patients

Sex: Female

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women 18-80 undergoing outpatient minimally invasive hysterectomy

Exclusion criteria

• Inability to provide informed consent
• Bladder malignancy
• Intra-operative bladder or ureteral injury; anticipated prolonged bladder catheterization
• Plan for sling or anterior repair

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

161 participants in 2 patient groups, including a placebo group

Tamsulosin- intervention group

Experimental group

Treatment:

Drug: Tamsulosin

Placebo group

Placebo Comparator group

Treatment:

Drug: Placebo